- Home
- CLDI vs LOBO Comparison
CLDI vs LOBO Comparison
Compare CLDI & LOBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- LOBO
- Stock Information
- Founded
- CLDI 2014
- LOBO 2014
- Country
- CLDI United States
- LOBO China
- Employees
- CLDI N/A
- LOBO N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- LOBO
- Sector
- CLDI Health Care
- LOBO
- Exchange
- CLDI Nasdaq
- LOBO NYSE
- Market Cap
- CLDI 14.0M
- LOBO 13.6M
- IPO Year
- CLDI N/A
- LOBO 2024
- Fundamental
- Price
- CLDI $0.48
- LOBO $0.80
- Analyst Decision
- CLDI Strong Buy
- LOBO
- Analyst Count
- CLDI 2
- LOBO 0
- Target Price
- CLDI $15.00
- LOBO N/A
- AVG Volume (30 Days)
- CLDI 386.9K
- LOBO 52.0K
- Earning Date
- CLDI 05-13-2025
- LOBO 04-29-2025
- Dividend Yield
- CLDI N/A
- LOBO N/A
- EPS Growth
- CLDI N/A
- LOBO N/A
- EPS
- CLDI N/A
- LOBO 0.00
- Revenue
- CLDI N/A
- LOBO $19,469,766.00
- Revenue This Year
- CLDI N/A
- LOBO $72.16
- Revenue Next Year
- CLDI N/A
- LOBO $41.04
- P/E Ratio
- CLDI N/A
- LOBO $741.89
- Revenue Growth
- CLDI N/A
- LOBO N/A
- 52 Week Low
- CLDI $0.35
- LOBO $0.46
- 52 Week High
- CLDI $4.90
- LOBO $3.52
- Technical
- Relative Strength Index (RSI)
- CLDI 38.44
- LOBO N/A
- Support Level
- CLDI $0.41
- LOBO N/A
- Resistance Level
- CLDI $0.45
- LOBO N/A
- Average True Range (ATR)
- CLDI 0.07
- LOBO 0.00
- MACD
- CLDI 0.02
- LOBO 0.00
- Stochastic Oscillator
- CLDI 56.57
- LOBO 0.00
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About LOBO LOBO EV TECHNOLOGIES LTD
Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.